In deliveryUnited KingdomGoods£9,489,301
Ustekinumab
- Published
- Published 15 December 2025
- Deadline
- Closed 9 March 2026
Overview
NHS Wales Shared Services Partnership procured the supply of Ustekinumab, a pharmaceutical product, with an estimated value of £9.49 million. The contract was awarded on 3 June 2026 for £6.53 million to six suppliers: Amgen Ltd, Celltrion Healthcare, Fresenius Kabi Ltd, Gedeon Richter, Sandoz Ltd, and Thornton & Ross. Delivery is now complete.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £9,489,301
- Procedure
- Open
- SME suitable
- Yes
- Published
- 15 December 2025
- Questions by
- 6 March 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £6,532,463
- Award date
- 3 June 2026
- Contract period
- 30 September 2026 → 30 June 2028
- Amgen Ltd
- Celltrion Healthcare
- Fresenius Kabi Ltd
- Gedeon Richter
- Sandoz Ltd
- Thornton & Ross
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
15 June 2026
View notice ↗Contract Notice
2 February 2026
View notice ↗Prior Information Notice
15 December 2025
View notice ↗
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
BuyerCardiff, United Kingdom
GB-NHS: RQF
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.